Identification and characterization of novel infection associated transcripts in macrophages.
Prabhakar ArumugamMohit SinglaRakesh LodhaVivek RaoPublished in: RNA biology (2021)
By analysis of lncRNA expression profiles of macrophages in response to Mycobacterium tuberculosis (Mtb) infection, we identified novel highly expressed transcripts, unique in encompassing a protein coding transcript- Cytidine Monophosphate Kinase 2 (CMPK2) and a previously identified lncRNA- Negative Regulator of Interferon Response (NRIR). While these transcripts (TILT1, 2,3 - TLR4 and Infection induced Long Transcript) are induced by virulent Mtb as well as lipopolysaccharide (LPS) early, lack of/delayed expression in non-viable Mtb/BCG infected cells, respectively, suggest an important role in macrophage responses. The elevated expression by 3 hr in response to fast growing bacteria further emphasizes the importance of these RNAs in the macrophage infection response. Overall, we provide evidence for the presence of multiple transcripts that form a part of the early infection response programme of macrophages.Abbreviations: IFN: Interferon; NRIR: negative regulator of interferon response; CMPK2: cytidine/ uridine monophosphate kinase; LPS: lipopolysaccharide; LAM: Lipoarabinomannan; PIMs: Phosphatidylinositol Mannosides; TILT1, 2,3: TLR4 and Infection induced Long Transcript; TLR4: Toll-like receptor 4; Mtb: Mycobacterium tuberculosis; BCG: Mycobacterium bovis BCG; MDMs: human monocyte derived macrophages.
Keyphrases
- mycobacterium tuberculosis
- toll like receptor
- inflammatory response
- pulmonary tuberculosis
- dendritic cells
- immune response
- nuclear factor
- poor prognosis
- clinical trial
- endothelial cells
- cell death
- adipose tissue
- long non coding rna
- induced apoptosis
- tyrosine kinase
- rna seq
- lps induced
- drug induced
- binding protein
- cell proliferation
- cell cycle arrest
- randomized controlled trial
- oxidative stress
- diabetic rats
- endoplasmic reticulum stress
- anti inflammatory
- amino acid
- pluripotent stem cells